Cargando…
Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer
Ovarian cancer (OC) is the most lethal gynecological cancer. OC cells have high proliferative capacity, are invasive, resist apoptosis, and tumors often display rearrangement of extracellular matrix (ECM) components, contributing to accelerated tumor progression. The multifunctional protein tissue t...
Autores principales: | Condello, Salvatore, Prasad, Mayuri, Atwani, Rula, Matei, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358478/ https://www.ncbi.nlm.nih.gov/pubmed/35810788 http://dx.doi.org/10.1016/j.jbc.2022.102242 |
Ejemplares similares
-
The Outside-In Journey of Tissue Transglutaminase in Cancer
por: Sima, Livia Elena, et al.
Publicado: (2022) -
Effects of integrin-linked kinase on protein kinase b, glycogen synthase kinase-3β, and β-catenin molecules in ovarian cancer cells
por: Sarı Kılıçaslan, Seda Mehtap, et al.
Publicado: (2021) -
Tissue Transglutaminase Is an Integrin-Binding Adhesion Coreceptor for Fibronectin
por: Akimov, Sergey S., et al.
Publicado: (2000) -
Beta-Catenin Regulated ALDH1A1 is a Target in Ovarian Cancer
Spheroids
por: Condello, Salvatore, et al.
Publicado: (2014) -
Transglutaminase Type 2 regulates the Wnt/β-catenin pathway in vertebrates
por: Rossin, Federica, et al.
Publicado: (2021)